Medical Procedure News

RSS

Rising kidney disease a worry – home dialysis may solve some problems

Kidney Health Australia (KHA) has released a report that predicts that the number of people needing treatment for serious kidney disease will triple to 30,000 by 2020 and treating serious kidney disease will cost the health system $12 billion over the next decade. The report, by the George Institute for Global Health, also found the annual cost of providing dialysis treatment was just over $79,000 per patient. This was compared to just over $49,000 per person taking part in a program which delivers the treatment not in a hospital but in the patient’s home.

5 Nov 2010

Most kidney care providers opt to participate in new Medicare 'bundled' payment system: Study

The Kidney Care Council (KCC), a nonprofit national health care association composed of leading kidney dialysis provider companies who care for a majority of ESRD patients nationwide, released new data today revealing that 98 percent of kidney care providers participating in a recent study have opted to participate in the new Medicare "bundled" payment system in January 2011, more than twice the rate originally anticipated.

4 Nov 2010

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT(R) (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.

4 Nov 2010

RF Surgical introduces new RF Assure Detection platform

RF Surgical Systems, Inc., the market leader in the prevention and detection of retained surgical sponges, today announced the availability of the RF Assure™ Detection System Model 200.

4 Nov 2010

Level of prostate-specific protein after salvage radiation therapy predicts mortality and disease progression

Removal of the prostate gland often eradicates early-stage cancer. But patients whose cancer has spread may need to follow up with what is known as salvage radiation therapy. Researchers at Fox Chase have now determined a better way to monitor outcomes after this procedure.

4 Nov 2010

Loyola University surgeon uses new technique to reopen blockages in coronary arteries

In some heart patients, coronary arteries become so clogged that they are difficult or impossible to reopen with conventional balloon angioplasties. Dr. John Lopez of Loyola University Health System is using a new angioplasty technique to reopen these tough blockages by going through the "back door." The technique, called retrograde recanalization, was developed in Japan and is beginning to catch on in centers with advanced expertise in cardiac catheterization.

4 Nov 2010

Combination of DC-CIK and stem cell therapy effective to prevent cancer recurrence after surgery

"For brain cancer patients after surgery, the combined DC-CIK and stem cell therapy from Cellonis Biotechnologies can be a very effective method in preventing cancer recurrence," says renowned cancer doctor Dr. Dinggang Li.

4 Nov 2010

Endocrine Society unveils new guideline on endocrine and nutritional management of post-bariatric surgery patients

The Endocrine Society released a new clinical practice guideline for the nutritional and endocrine management of adults after bariatric surgery, including those with diabetes mellitus. The guideline features a series of evidence-based clinical recommendations developed by an expert task force. The guideline is published in the November 2010 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.

4 Nov 2010

Synageva receives $2.3 million under QTDP program

Synageva BioPharma Corp., a privately held biopharmaceutical company developing novel treatments for rare diseases, today announced that the US Treasury Department awarded approximately $2.3 million to Synageva BioPharma as part of the Qualifying Therapeutic Discovery Project Program.

4 Nov 2010

New laparoscopic instrument mimics human index finger

Microline Surgical, a leading manufacturer of reposable instruments for minimally invasive surgery, today announced the launch of its LapFinger™ finger activated laparoscopic instrument. LapFinger mimics the ultimate dissection tool - the human index finger - enabling surgeons to dissect with confidence, retract with strength and palpate with feel.

4 Nov 2010

One-third of breast cancer survivors rate breast-conserving treatments as fair

A third of breast cancer survivors who received the breast-conserving treatments lumpectomy and radiation rate the appearance of their post-treatment breast as only "fair" or "poor" in comparison to their untreated breast, according to a new University of Pennsylvania School of Medicine study that will be presented today at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego.

3 Nov 2010

Fibrocell, Meifu to develop and market autologous fibroblast therapies in Asia

Fibrocell Science, Inc. a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has signed an agreement to establish a joint venture (JV) with Hefei Meifu Bio-Tech Limited Co. for developing and marketing autologous fibroblast therapies in Asia, excluding Japan. The JV will be called Fibrocell Science Asia Co. Ltd.

3 Nov 2010

IDEV receives FDA marketing clearance for SUPERA VERITAS Transhepatic Biliary System

IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance to market the SUPERA VERITAS Transhepatic Biliary System.

3 Nov 2010

MiCardia receives European CE Mark approval for enCor Mitral Valve Repair System

MiCardia Corporation announced today that it has received the CE Mark to begin marketing the Company's enCor™ Mitral Valve Repair System in the European Union.

3 Nov 2010

Radiation oncologist says radiation quality assurance practices need to be standardized

In 2009, after The New York Times reported a series of mistakes in radiation therapy delivery, a team of radiation oncologists at the Kimmel Cancer Center at Jefferson decided to investigate how thoroughly different hospitals use "chart rounds" to review the radiotherapy cancer patients receive.

3 Nov 2010

Retina Implant's microchip restores useful vision in patients blind due to retinitis pigmentosa

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the publication of a peer-reviewed study in Proceedings of the Royal Society B discussing the technical and clinical results obtained during their first human clinical trial.

3 Nov 2010

Study finds risk of toxicity in Phase I radiation oncology clinical trials

Risks to patients enrolled in Phase I radiation oncology clinical trials are higher than previously appreciated, according to a study conducted by researchers from the Kimmel Cancer Center at Jefferson. The findings will be presented at the American Society of Radiation Oncology (ASTRO) annual meeting in San Diego.

3 Nov 2010

Image Guided IMRT preserves sexual function in men after prostatectomy

Men battling prostate cancer who receive Image Guided Intensity Modulated Radiation Therapy after undergoing prostatectomy have an excellent chance of retaining sexual function, according to a study by Allegheny General Hospital (AGH) cancer specialists presented this week at the annual meeting of the American Society for Therapeutic Radiation and Oncology in San Diego.

3 Nov 2010

Roux-en-Y gastric bypass surgery effective for morbid obesity

Gastric bypass surgery decreases the preference for sweet-tasting substances in obese rats, a study finding that could help in developing safer treatments for the morbidly obese, according to Penn State College of Medicine researchers.

3 Nov 2010

JenaValve commences CE-Mark study for transapical TAVI system

JenaValve™ Technology, Inc., a medical device company specialized in developing transcatheter valve replacement products, announced today the start of its multicenter CE-mark study. The first two implantations of its transapical TAVI system were performed by Dr. med. Hendrik Treede at the Universitäres Herzzentrum Hamburg.

3 Nov 2010

Medical Procedure News

Rising kidney disease a worry – home dialysis may solve some problems

Most kidney care providers opt to participate in new Medicare 'bundled' payment system: Study

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

RF Surgical introduces new RF Assure Detection platform

Level of prostate-specific protein after salvage radiation therapy predicts mortality and disease progression

Loyola University surgeon uses new technique to reopen blockages in coronary arteries

Combination of DC-CIK and stem cell therapy effective to prevent cancer recurrence after surgery

Endocrine Society unveils new guideline on endocrine and nutritional management of post-bariatric surgery patients

Synageva receives $2.3 million under QTDP program

New laparoscopic instrument mimics human index finger

One-third of breast cancer survivors rate breast-conserving treatments as fair

Fibrocell, Meifu to develop and market autologous fibroblast therapies in Asia

IDEV receives FDA marketing clearance for SUPERA VERITAS Transhepatic Biliary System

MiCardia receives European CE Mark approval for enCor Mitral Valve Repair System

Radiation oncologist says radiation quality assurance practices need to be standardized

Retina Implant's microchip restores useful vision in patients blind due to retinitis pigmentosa

Study finds risk of toxicity in Phase I radiation oncology clinical trials

Image Guided IMRT preserves sexual function in men after prostatectomy

Roux-en-Y gastric bypass surgery effective for morbid obesity

JenaValve commences CE-Mark study for transapical TAVI system

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News